Feedback
Contact
Calendar
Employment
RFP
Français
myGAVI
RSS & Follow
Lowband
Home
About the Alliance
Learn more about GAVI
GAVI's mission
What we do
GAVI's impact
Challenges and opportunities
Gender and immunisation
Why invest in GAVI?
Advocates
GAVI's strategy
Value of vaccination
GAVI's partnership model
GAVI's business model
Global health and development
Governing GAVI
GAVI Board
GAVI Secretariat
GAVI Internal Audit
Finance & Programmatic policies
Types of support
What GAVI offers and how it works
Apply for support
New and underused vaccines support
Hepatitis B vaccine
Hib vaccine
Human papillomavirus vaccine
Injection safety support
Measles second dose
Meningitis A vaccine
Pneumococcal vaccine
Rubella vaccine
Rotavirus vaccine
Yellow fever vaccine
Immunisation services support
Health Systems Funding Platform
Health system strengthening
Civil society organisation
Country hub
Afghanistan
Albania
Angola
Armenia
Azerbaijan
Bangladesh
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic (the)
Chad
China
Comoros
Congo
Congo, DR
Côte d’Ivoire
Cuba
Djibouti
Eritrea
Ethiopia
Gambia
Georgia
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Kenya
Kiribati
Korea, DPR
Kyrgyzstan
Lao PDR
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Moldova
Mongolia
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Papua New Guinea
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Tajikistan
Tanzania, UR
Timor Leste
Togo
Turkmenistan
Uganda
Ukraine
Uzbekistan
Vietnam
Yemen
Zambia
Zimbabwe
Funding & finance
Long-term financial commitments
Save lives, give to GAVI
How GAVI is funded
Key figures: donor contributions & pledges
Donor profiles
Resource mobilisation
GAVI’s resource mobilisation process
GAVI's funding challenge
Financial reports
Pneumococcal AMC
Results & evidence
Measuring & evaluating performance
Goal-level indicators
Mission indicators
Vaccine goal indicators
Health systems goal indicators
Financing goal indicators
Market-shaping goal indicators
Countries approved for support
Disbursements by country
GAVI's evaluation studies
GAVI first evaluation report
GAVI second evaluation report
International Finance Facility for Immunisation evaluation
Other studies
GAVI Progress reports
Library & news
Search by topic, country and programme
News
Press releases
Statements
Return on investment stories
GAVI features
GAVI blogs
Audio-visual
Board & committee minutes
GAVI documents
Country documents
Evaluations
Financial reports
Guidelines and forms
Policies
Strategy
Supply and procurement
Publications
Events
You are here:
Library
Audio-visual
Audio-visual
Galleries
Galleries
Pneumococcal vaccines introduced in Malawi
Pneumococcal vaccines introduced in Malawi
in page functions
On 12 November 2011, World Pneumonia Day, Malawi became the 16th GAVI-eligible country to introduce the pneumococcal vaccine, protecting children in the country against the leading cause of pneumonia.
12 November 2011
Doune Porter/GAVI/2011
In the arms of his mother Janet, two-month old Bright Masambo Chisale is the first baby in Malawi to be given a pneumococcal vaccine. Vaccinator Clement Saidi was proud to deliver the first vaccine in front the Minister of Health, Dr. Jean Kalilani, and a large crowd of onlookers, which included Malawian and international journalists.
Doune Porter/GAVI/2011
At the launch of pneumococcal vaccines in Malawi on World Pneumonia Day, 12 November 2011, Dr. Jane Muita, Deputy Representative of UNICEF, a key GAVI Alliance partner, makes a presentation on behalf of the Alliance.
Doune Porter/GAVI/2011
A colourful carnival through the streets of the Malawian capital Lilongwe on World Pneumonia Day, November 12, led the way to the ceremonial launch of pneumococcal vaccines, which will protect children in the country against the leading cause of pneumonia. Crowds danced to traditional Malawian music celebrating this milestone in the fight against pneumonia.
Doune Porte/GAVI/2011
On World Pneumonia Day, November 12, Kingsley Kuthu brought his four month-old daughter Ngesa to watch the street carnival in Lilongwe, organised to celebrate the launch in Malawi of pneumococcal vaccines. The new vaccines will protect children like Ngesa from pneumococcal disease, the leading cause of pneumonia.
Doune Porter/GAVI/2011
Dancers celebrating the launch of pneumococcal vaccines on November 12 in Lilongwe, Malawi.
Doune Porter/GAVI/2011
The theme for an entertaining acrobatic display by the Malawian defence forces at the pneumococcal vaccine launch on November 12 in Lilongwe was "fighting pneumonia."
Share this gallery
Latest Galleries
The human tragedy and the hope behind Ghana’s historic decision
Model immunisation system sets standard for Mozambique
Seth Berkley in Mozambique March 2012
Chad’s campaign against meningitis A
GAVI’s Matching Fund announcement at WEF
Laos' efforts to stop rubella and measles for good
The toll of cervical cancer
Civil society in Bangladesh
Immunisation in Bangladesh
Pneumococcal vaccines introduced in Malawi
View all latest galleries
Related Library items
New studies show progress, value in vaccination against deadly pneumonia
Related information
Pneumococcal vaccine support timeline
Pneumococcal vaccine support
Rotavirus vaccine support
Search keywords
Pneumococcal
WPD
pneumonia
modal window here